Hutchmed China Ltd

HUTCHMED (China) Limited (HCM) - Yahoo Finance

Valuation Measures · Market Cap. 2.86B · Enterprise Value. 2.14B · Trailing P/E. 32.30 · Forward P/E. 56.82 · PEG Ratio (5yr expected). -- · Price/Sales (ttm).

HUTCHMED China Ltd - Company Profile and News - Bloomberg

Company profile page for HUTCHMED China Ltd including stock price, company news, executives, board members, and contact information.

HUTCHMED - LinkedIn

HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development ...

HUTCHMED (CHINA) LIMITED HCM Stock | London Stock Exchange

HUTCHMED (CHINA) LIMITED HCM Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.

Hutchmed China Ltd - Company Profile - GlobalData

Hutchmed China Ltd (Hutchmed) formerly known as Hutchison China MediTech Ltd is a biopharmaceutical company which discovers, develops, manufactures and ...

HUTCHMED (China) Ltd (HCM) Stock Price & News - Google Finance

Get the latest HUTCHMED (China) Ltd (HCM) real-time quote, historical performance, charts, and other financial information to help you make more informed ...

HUTCHMED (China) Ltd, HCM:LSE summary - FT.com - Markets data

Latest HUTCHMED (China) Ltd (HCM:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

HUTCHMED (China) Limited (HCM) Company Profile & Facts

See the company profile for HUTCHMED (China) Limited (HCM) including business summary, industry/sector information, number of employees, business summary, ...

HUTCHMED (China) Limited - Crunchbase Company Profile ...

HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company.

HUTCHMED China Ltd - Company Profile and News - Bloomberg.com

HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment.

HUTCHMED (China) Limited - GlobeNewswire

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”, the “Company” or “we”) (Nasdaq/AIM:HCM; ...

HUTCHMED (China) Limited American Depositary Shares (HCM)

Discover real-time HUTCHMED (China) Limited American Depositary Shares (HCM) stock prices, quotes, historical data, news, and Insights for informed trading ...

HUTCHMED (China) Ltd, 13:HKG summary - FT.com - Markets data

Latest HUTCHMED (China) Ltd (13:HKG) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

HUTCHMED (China) Ltd - Reuters

The latest international HUTCHMED (China) Ltd news and views from Reuters - one of the world's largest news agencies.

HUTCHMED (China) Limited | Insights - Citeline

Other Names/Subsidiaries · Chi-Med · Hutchison Whampoa · Sinopharm Pharmaceuticals Company Limited · Hutchison MediPharma Limited · Hutchison China MediTech Limited ...

HUTCHMED (China) Ltd 13-HK:Hong Kong Stock Exchange - CNBC

Get HUTCHMED (China) Ltd (13-HK:Hong Kong Stock Exchange) real-time stock quotes, news, price and financial information from CNBC.

Hutchmed (China) Ltd. - BioWorld

The newly renamed Hutchmed (China) Ltd., previously known as Hutchison China Meditech Ltd. (Chi-Med), plans to sell $100 million of its American depository ...

Hutchmed (China) Limited Share Price (HCM) ORD USD0.10

Hutchmed (China) Limited (HCM) ORD USD0.10 ; Year low · 190.40p ; P/E ratio · 27.97 ; Previous · 3.00p ; Volume · 39,973 ; Dividend yield · n/a.

HUTCHMED (China) Ltd. - Drug pipelines, Patents, Clinical trials

Fruquintinib plus paclitaxel as a second-line treatment significantly improved PFS, but not OS, in Chinese patients with advanced gastric or gastroesophageal ...